Helen Albert

A CRISPR gene editing protein called Cas12a2 can be turned into a kind of programmable self‑destruct switch for cells, which researchers think could be a new way to treat conditions like cancer if the technique is validated.

Women with endometriosis have a small but significant increased risk for having babies with birth defects, such as those affecting the heart, gastric, genital, or musculoskeletal system, compared with women without the condition.

Five factors predicting death or serious complications in hypertrophic cardiomyopathy, a heart condition where the heart muscle becomes abnormally thick, have been uncovered in a study led by the University of Virginia.

Swiss research shows treatment with an antibody known as NG101 promotes regeneration of damaged spinal cord tissue in some people with spinal cord

A type of exchange marketplace for cell and gene therapies has launched to try and reinvigorate and relaunch candidate therapies that are no longer

Microbiotica, a microbiome-focused biotech based in Cambridge in the U.K., has achieved good Phase Ib results in a trial of its microbiome therapy for patients with advanced melanoma skin cancer.

Anti-inflammatory drugs that block interleukin-6 could help relieve symptoms of depression in some difficult-to-treat patients.

A type of cell therapy made up of macrophage cells can lower risk for death or need for a liver transplant in people with cirrhosis due to advanced liver disease.

Removing precancerous polyps from the gut might not be enough to remove colorectal cancer risk, as gut microbes may also play a role.

A new imaging agent plus SPECT imaging can differentiate inflammation from scarring in the lungs in patients with interstitial lung disease.